🇺🇸 FDA
Patent

US 7427598

Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory

granted A61KA61K38/00A61P

Quick answer

US patent 7427598 (Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Sep 23 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/00, A61P, A61P17/02, A61P21/04